$221 Million is the total value of Endurant Capital Management LP's 51 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 57.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CI | Sell | CIGNA CORP NEW | $12,656,000 | -23.3% | 71,428 | -11.5% | 5.74% | +10.3% |
| ANTM | Sell | ANTHEM INC | $9,842,000 | -60.3% | 43,351 | -47.2% | 4.46% | -42.9% |
| ZBH | Sell | ZIMMER BIOMET HOLDINGS INC | $9,511,000 | -53.3% | 94,096 | -30.9% | 4.31% | -32.9% |
| BMY | Sell | BRISTOL-MYERS SQUIBB CO | $7,632,000 | -70.4% | 136,925 | -65.9% | 3.46% | -57.4% |
| BDX | Sell | BECTON DICKINSON & CO | $7,123,000 | -54.2% | 31,000 | -45.7% | 3.23% | -34.1% |
| EHC | Sell | ENCOMPASS HEALTH CORP | $3,561,000 | -68.5% | 55,614 | -65.9% | 1.61% | -54.7% |
| LH | Sell | LABORATORY CORP AMER HLDGS | $3,330,000 | -81.8% | 26,344 | -75.6% | 1.51% | -73.8% |
| PRAH | Sell | PRA HEALTH SCIENCES INC | $3,223,000 | -50.8% | 38,817 | -34.2% | 1.46% | -29.2% |
| HRC | Sell | HILL ROM HLDGS INC | $2,640,000 | -64.7% | 26,240 | -60.1% | 1.20% | -49.2% |
| XRAY | Sell | DENTSPLY SIRONA INC | $2,044,000 | -36.3% | 52,645 | -7.2% | 0.93% | -8.4% |
| GWPH | Sell | GW PHARMACEUTICALS PLCads | $1,479,000 | -52.4% | 16,890 | -43.2% | 0.67% | -31.5% |
| FATE | Sell | FATE THERAPEUTICS INC | $905,000 | -65.7% | 40,732 | -69.8% | 0.41% | -50.7% |
| IQV | Sell | IQVIA HLDGS INC | $899,000 | -88.3% | 8,332 | -83.3% | 0.41% | -83.2% |
| IOVA | Sell | IOVANCE BIOTHERAPEUTICS INC | $605,000 | -87.0% | 20,207 | -88.0% | 0.27% | -81.4% |
| FLDM | Sell | FLUIDIGM CORP DEL | $590,000 | -83.6% | 232,291 | -77.5% | 0.27% | -76.5% |
| PRNB | Sell | PRINCIPIA BIOPHARMA INC | $530,000 | -85.4% | 8,927 | -86.5% | 0.24% | -79.0% |
| MGNX | Sell | MACROGENICS INC | $510,000 | -61.9% | 87,703 | -28.6% | 0.23% | -45.1% |
| ACRS | Exit | ACLARIS THERAPEUTICS INCcall | $0 | – | -376,200 | -100.0% | -0.03% | – |
| PTI | Exit | PROTEOSTASIS THERAPEUTICS INcall | $0 | – | -47,400 | -100.0% | -0.03% | – |
| ATNM | Exit | ACTINIUM PHARMACEUTICALS INC | $0 | – | -677,086 | -100.0% | -0.05% | – |
| DRNA | Exit | DICERNA PHARMACEUTICALS INC | $0 | – | -13,768 | -100.0% | -0.10% | – |
| WMGI | Exit | WRIGHT MED GROUP N V | $0 | – | -11,669 | -100.0% | -0.11% | – |
| STRO | Exit | SUTRO BIOPHARMA INC | $0 | – | -32,666 | -100.0% | -0.11% | – |
| SDC | Exit | SMILEDIRECTCLUB INC | $0 | – | -59,178 | -100.0% | -0.16% | – |
| APLS | Exit | APELLIS PHARMACEUTICALS INC | $0 | – | -19,362 | -100.0% | -0.19% | – |
| NCNA | Exit | NUCANA PLCsponsored adr | $0 | – | -109,150 | -100.0% | -0.21% | – |
| TNDM | Exit | TANDEM DIABETES CARE INC | $0 | – | -21,361 | -100.0% | -0.40% | – |
| LQDA | Exit | LIQUIDIA TECHNOLOGIES INC | $0 | – | -317,993 | -100.0% | -0.43% | – |
| CNMD | Exit | CONMED CORP | $0 | – | -17,940 | -100.0% | -0.63% | – |
| SILK | Exit | SILK ROAD MEDICAL INC | $0 | – | -51,303 | -100.0% | -0.65% | – |
| ADVM | Exit | ADVERUM BIOTECHNOLOGIES INC | $0 | – | -214,823 | -100.0% | -0.78% | – |
| BAX | Exit | BAXTER INTL INC | $0 | – | -34,151 | -100.0% | -0.90% | – |
| MDRX | Exit | ALLSCRIPTS HEALTHCARE SOLUTN | $0 | – | -447,986 | -100.0% | -1.38% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INC | $0 | – | -39,822 | -100.0% | -1.62% | – |
| SPY | Exit | SPDR S&P 500 ETF TRput | $0 | – | -16,600 | -100.0% | -1.68% | – |
| EVH | Exit | EVOLENT HEALTH INCcl a | $0 | – | -597,303 | -100.0% | -1.70% | – |
| IRTC | Exit | IRHYTHM TECHNOLOGIES INC | $0 | – | -89,614 | -100.0% | -1.92% | – |
| ABBV | Exit | ABBVIE INC | $0 | – | -98,596 | -100.0% | -2.75% | – |
| REGN | Exit | REGENERON PHARMACEUTICALS | $0 | – | -27,390 | -100.0% | -3.24% | – |
| ABC | Exit | AMERISOURCEBERGEN CORP | $0 | – | -218,820 | -100.0% | -5.86% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LABORATORY CORP AMER HLDGS | 31 | Q2 2023 | 8.7% |
| ELEVANCE HEALTH INC | 29 | Q3 2023 | 8.8% |
| BECTON DICKINSON & CO | 28 | Q2 2023 | 9.8% |
| MCKESSON CORP | 27 | Q1 2023 | 4.4% |
| CENCORA INC | 26 | Q3 2023 | 5.9% |
| HOLOGIC INC | 24 | Q3 2023 | 7.5% |
| JOHNSON & JOHNSON | 24 | Q4 2021 | 5.5% |
| ZIMMER HLDGS INC | 23 | Q3 2023 | 7.5% |
| BOSTON SCIENTIFIC CORP | 22 | Q3 2023 | 5.5% |
| DAVITA INC | 22 | Q1 2021 | 4.9% |
View Endurant Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AZIYO BIOLOGICS, INC. | March 21, 2023 | 576,253 | 4.9% |
| Oxford Immunotec Global PLCSold out | February 17, 2021 | 0 | 0.0% |
View Endurant Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-07 |
| SC 13D/A | 2024-04-10 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| SC 13D/A | 2023-09-08 |
| 13F-HR | 2023-08-14 |
| 3/A | 2023-05-24 |
| 13F-HR | 2023-05-15 |
| 3 | 2023-05-15 |
| SC 13D | 2023-05-15 |
View Endurant Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.